Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Clarke who wrote (32288)	1/14/1999 11:21:00 AM
From: jeffrey rainey	Read Replies (1) \| Respond to of 34592

LA JOLLA, CALIF. (Jan. 14) BW HEALTHWIRE -Jan. 14, 1999--La Jolla Diagnostics Inc. (OTC BB:LAJD), announced today that its subsidiary DiagnosTech Inc. has received confirmation that clinical trials on the company's rapid diagnostic TB test have been successfully completed at Beijing Children's Hospital. This proprietary, patent pending rapid diagnostic test for active tuberculosis is a unique breakthrough product for a disease which is a major problem in many countries. The accuracy of this TB test has been confirmed in three separate clinical trials, and it is currently being sold in several countries with approvals pending in numerous others. Presently there is no other test available that can rapidly determine if the disease is an active state. DiagnosTech's Hong Kong based distributor, Winnimax, plans to submit a formal registration application for the product to the Chinese Ministry of Health this coming March. The World Health Organization (WHO) projects that a total of 1 billion TB tests will be performed annually by the year 2000. Approximately 25 percent of active TB cases occur in China. La Jolla Diagnostics is an emerging company engaged in the development and marketing of state-of-the-art diagnostic tests, health care products and nutraceuticals. The health care and nutraceuticals products, including a treatment for migraine headaches, are formulated using a patented technology. -0- jm/sd* sf/sd CONTACT: La Jolla Diagnostics Inc. 800/454-6790, Fax 619/454-7851 lajd.com lajd96@aol.com

To: Kevin Clarke who wrote (32288)	1/14/1999 11:56:00 AM
From: Gator	Respond to of 34592

Ground floor (and timely) internet play: SDMT (shell co.) will complete a reverse merger with IBN, International Net Broadcasting "very shortly", according to SDMT's IR. IBN runs internet content web sites. Present market cap, based on 8.5 million shares X $2 5/8 closing price yesterday = $22.5 million. Approximately 1.5 million in float. I am told that most of the shares will actually be held by insiders, with some of this restricted for one year. Stock is starting its move today. IBN's Entertainment Boulevard web site has big name advertisers, link to AMZN, etc. Vidnet offers music videos for viewing, and is highly-rated in the industry for technical quality. Screen clips offers movie clips. Pro Sports Net is a sports site with Tim McCarver interviews and other sports content. See their web sites at: vidnetusa.com entertainmentblvd.com screenclips.com prosportsnet.com Merger to be executed possibly this Fri. From a discussion I just had with PR (at 888-649-5622, took me forever to get thru, lots of busy signals), I asked if the reverse merger was still on. He replied "It is very much on". I asked if it will completed soon, he said "very soon". I asked "Friday soon", he replied "very, very soon". The sites got more than 10 million hits in November. December hits were reported to be well over 20 million hits. From March to October, unique visits popped from 50,000 to 500,000. Gator